Paradoxical effects of clinician emphasis on adherence to combination antiretroviral therapy for HIV/AIDS

AIDS Patient Care and STDs

Volumn 20, Issue 4, 2006, Pages 269-274

  Tugenberg, Toni ^a   Ware, Norma C ^a   Wyatt, Monique A ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ILLICIT DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; DOCTOR PATIENT RELATION; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PATIENT COMPLIANCE; PROBLEM SOLVING; QUALITATIVE ANALYSIS; TREATMENT OUTCOME; TRUST;

ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COMMUNICATION; FEMALE; HIV INFECTIONS; HUMANS; INTERVIEWS; MALE; PATIENT COMPLIANCE; PHYSICIAN-PATIENT RELATIONS; PHYSICIANS; SUBSTANCE-RELATED DISORDERS;

EID: 33646100080     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.2006.20.269     Document Type: Article

References (27)

1. Paterson DL, Swindells S, Mohr JA, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000;133:21-30.
2. Howard AA, Arnsten JH, Lo Y, et al. A prospective study of adherence and viral load in a large multicenter cohort of HIV-infected women. AIDS 2002;16:2175-2182.
3. Bangsberg DR, Hecht FM, Charlebois ED, et al. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS 2000;14:357-366.
4. Golin CE, Liu HH, Hays RD, et al. A prospective study of predictors of adherence to combination anti-retroviral medication. J Gen Intern Med 2002;17:756-765.
5. Catz SL, Kelly JA, Bogart LM, Benotsch EG, McAuliffe TL. Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HTV disease. Health Psychol 2000;19:12-133.
6. Heckman BD, Catz SL, Heckman TG, Miller JG, Kalichman SC. Adherence to antiretroviral therapy in rural persons living with HIV disease in the United States. AIDS Care 2004;16:219-230.
7. Wainberg MA, Friedland G. Public health implications of antiretroviral therapy and HIV drug resistance. JAMA 1998;279:1977-1983.
8. Bangsberg DR, Moss AR. When should we delay highly active antiretoviral therapy? J Gen Intern Med 1999;14:446-448.
9. Sollitto S, Mehlman M, Youngner S, Lederman MM. Should physicians withhold highly active antiretroviral therapies from HIV-AIDS patients who are thought to be poorly adherent to treatment? AIDS 2001;15:153-159.
10. Altice FL, Friedland GH. The era of adherence to HIV therapy. Ann Intern Med 1998;129:503-505.
11. Schneider J, Kaplan SH, Greenfield S, Li W, Wilson IB. Better physician-patient relationships are associated with higher reported adherence to antiretroviral therapy in patients with HIV infection. J Gen Intern Med 2004;19:1096-1103.
12. Roberts KJ. Physician-patient relationships, patient satisfaction, and antiretroviral medication adherence among HIV-infected adults attending a public health clinic. AIDS Patient Care STDs 2002;16:43-50.
13. Malcolm SE, Ng JJ, Rosen RK, Stone VE. An examination of HIV/AIDS patients who have excellent adherence to HAART. AIDS Care 2003;15:251-261.
14. Murphy DA, Roberts KJ, Hoffman D, Molina A, Lu MC. Barriers and sucessful strategies to antiretroviral adherence among HIV-infected monolingual Spanish-speaking patients. AIDS Care 2003;15:217-230.
15. Murphy DA, Roberts KJ, Martin DJ, Marelich WD, Hoffman D. Barriers to antiretroviral adherence among HIV-infected adults. AIDS Patient Care and STDs 2000;14:47-58.
16. Wilson I, Coady W, Lu M. Relationship quality and antiretroviral (ART) medication adherence. Elements of Success: An International Conference on Adherence to Antiretroviral Therapy. December 2-4, 2004, Dallas, Texas.
17. Glaser B, Strauss A. Discovery of Grounded Theory. Chicago: Aldine, 1967.
18. Strauss A, Corbin J. Basic of Qualitative Research: Techniques and Procedures for Developing Grounded Theory. Thousand Oaks, CA: Sage, 1998.
19. Ware NC, Wyatt MA, Tugenberg T. Adherence, stereotyping and unequal HIV treatment for active users of illegal drugs. Soc Sci Med 2005;61:565-576.
20. Department of Health and Human Services. AIDS information. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. www.aidsinfo.nih.gov/guidelines/adult/AA_040705 (Last accessed April 5, 2005).
21. Golin CE, Smith SR, Reif S. Adherence counseling practices of generalist and specialist physicians caring for people living with HIV/AIDS in North Carolina. J Gen Intern Med 2004;19:16-27.
22. Harman JJ, Amico KR, Johnson BT. Standard of care: Promoting antiretroviral adherence in clinical care. AIDS Care 2005;17:237-251.
23. Yallop S, Lowth A, Fitzgerald MH, Reid J, Morelli A. The changing world of HIV care: The impact on health professionals. Cult Health Sex 2002;4:431-441.
24. Stone VE, Hogan JW, Schuman P, et al. Antiretroviral regimen complexity, self-reported adherence, and HIV patients' understanding of their regimens: Survey of women in the HER study. J Acquir Immune Defic Syndr 2001;28:124-131.
25. Miller LG, Liu HH, Hays RD, et al. Knowledge of antiretroviral regimen dosing and adherence: A longitudinal study. Clin Infect Dis 2003;36:514-518.
26. Tuldra A, Fumaz CR, Ferrer MJ, et al. Prospective randomized two-arm controlled study to determine the efficacy of a specific intervention to improve longterm adherence to highly active antiretroviral therapy. J Acquir Immune Defic Syndr Hum Retrovirol 2000;25:221-228.
27. Remien RH, Stirratt MJ, Dolezal C, et al. Couple-focused support to improve HIV medication adherence: A randomized controlled trial. AIDS 2005;19:807-814.